CT Radiogenomic Characterization of the Alternative Lengthening of Telomeres Phenotype in Pancreatic Neuroendocrine Tumors

被引:16
|
作者
McGovern, Jonathan M. [1 ]
Singhi, Aatur D. [2 ]
Borhani, Amir A. [1 ]
Furlan, Alessandro [1 ]
McGrath, Kevin M. [3 ]
Zeh, Herbert J., III [4 ]
Bahary, Nathan [5 ]
Dasyam, Anil K. [1 ]
机构
[1] Univ Pittsburgh, Div Abdominal Imaging, Dept Radiol, Med Ctr, 200 Lothrop St,E Wing E2051B,Ste 200, Pittsburgh, PA 15213 USA
[2] Univ Pittsburgh, Med Ctr, Dept Pathol, Pittsburgh, PA USA
[3] Univ Pittsburgh, Div Gastroenterol, Dept Internal Med, Med Ctr, Pittsburgh, PA USA
[4] UT Southwestern Med Ctr, Dept Surg, Dallas, TX USA
[5] Univ Pittsburgh, Div Oncol, Dept Internal Med, Med Ctr, Pittsburgh, PA USA
基金
美国国家卫生研究院;
关键词
alternative lengthening of telomeres (ALT); ATRX; CT; DAXX; neuroendocrine tumor; pancreas; pancreatic neuroendocrine tumor; radiomics; ENHANCED COMPUTED-TOMOGRAPHY; FEATURES; ENDOCRINE; SURVIVAL; GRADE;
D O I
10.2214/AJR.17.19490
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The objective of this study was to identify imaging characteristics in patients with known pancreatic neuroendocrine tumors (PanNETs) that predict the alternative lengthening of telomeres (ALT) phenotype by blinded retrospective review of preoperative multiphasic CT scans. MATERIALS AND METHODS. For this retrospective study of 121 preoperative CT examinations of patients with resected PanNETs, two radiologists independently reviewed the CT examinations for tumor characteristics including size, shape, cystic or necrotic elements, calcifications, invasion of adjacent organs and vessels, biliary duct dilatation, pancreatic duct dilatation, and hepatic metastases. Univariate analysis of association of CT characteristics with ALT phenotype was performed with Fisher exact tests or t tests, and multivariate analysis was assessed by multiple logistic regression. RESULTS. Univariate analysis showed that the following CT features were significantly associated with the ALT phenotype: lobulated or irregular tumor shape (p = 0.001), tumor necrosis (p = 0.002), vascular invasion (p < 0.001), pancreatic duct dilatation (p < 0.001), and hepatic metastasis (p < 0.001). Multivariate analysis found that the combination of pancreatic duct dilatation, hepatic metastasis, and size of tumor = 3 cm was a strong predictor of ALT phenotype (odds ratio = 20.3; 95% CI = 2.3-176.3; AUC = 0.58; p = 0.006). CONCLUSION. This study showed that several preoperative CT features of PanNETs are associated with the ALT phenotype, which is known to predict poor prognosis. Additionally, CT findings of intratumoral calcifications and metastases predicted poor survival independent of the ALT status.
引用
收藏
页码:1020 / 1025
页数:6
相关论文
共 50 条
  • [1] Alternative Lengthening of Telomeres Predicts Metastatic Disease and Poor Survival in Patients With Pancreatic Neuroendocrine Tumors
    Kinowaki, Y.
    Matsuda, Y.
    Fukumura, Y.
    Kudo, A.
    Akashi, T.
    Kitagawa, M.
    PANCREAS, 2019, 48 (10) : 1462 - 1462
  • [2] Alternative lengthening of telomeres and ATRX/DAXX loss can be reliably detected in FNAs of pancreatic neuroendocrine tumors
    VandenBussche, Christopher J.
    Allison, Derek B.
    Graham, Mindy K.
    Charu, Vivek
    Lennon, Anne Marie
    Wolfgang, Christopher L.
    Hruban, Ralph H.
    Heaphy, Christopher M.
    CANCER CYTOPATHOLOGY, 2017, 125 (07) : 544 - 551
  • [3] The diagnostic and prognostic utility of incorporating DAXX, ATRX, and alternative lengthening of telomeres to the evaluation of pancreatic neuroendocrine tumors
    Heaphy, Christopher M.
    Singhi, Aatur D.
    HUMAN PATHOLOGY, 2022, 129 : 11 - 20
  • [4] Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
    Claudio Luchini
    Rita T. Lawlor
    Samantha Bersani
    Caterina Vicentini
    Gaetano Paolino
    Paola Mattiolo
    Antonio Pea
    Sara Cingarlini
    Michele Milella
    Aldo Scarpa
    Current Oncology Reports, 2021, 23
  • [5] Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival
    Kim, Joo Young
    Brosnan-Cashman, Jacqueline A.
    An, Soyeon
    Kim, Sung Joo
    Song, Ki-Byung
    Kim, Min-Sun
    Kim, Mi-Ju
    Hwang, Dae Wook
    Meeker, Alan K.
    Yu, Eunsil
    Kim, Song Cheol
    Hruban, Ralph H.
    Heaphy, Christopher M.
    Hong, Seung-Mo
    CLINICAL CANCER RESEARCH, 2017, 23 (06) : 1598 - 1606
  • [6] Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
    Luchini, Claudio
    Lawlor, Rita T.
    Bersani, Samantha
    Vicentini, Caterina
    Paolino, Gaetano
    Mattiolo, Paola
    Pea, Antonio
    Cingarlini, Sara
    Milella, Michele
    Scarpa, Aldo
    CURRENT ONCOLOGY REPORTS, 2021, 23 (09)
  • [7] Alternative Lengthening of Telomeres (ALT) Predicts Disease Free Survival in Small Well Differentiated Pancreatic Neuroendocrine Tumors
    Memon, Raima
    Pisipati, Sailaja
    Al Diffalha, Sameer
    Hartley, Christopher
    Rose, J. Bart
    Reid, Michelle
    Gleeson, Ferga
    Graham, Rondell
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1846 - S1847
  • [8] Alternative Lengthening of Telomeres Is Associated With Aggressive Pathologic Features and Increased Recurrence Risk in Large Pancreatic Neuroendocrine Tumors
    Gudmundsdottir, Hallbera
    Graham, Rondell P.
    Smoot, Rory L.
    Truty, Mark J.
    Kendrick, Michael L.
    Nagorney, David M.
    Cleary, Sean P.
    Halfdanarson, Thorvardur R.
    PANCREAS, 2022, 51 (03) : E48 - E49
  • [9] The Diagnostic and Prognostic Utility of Incorporating DAXX, ATRX, and Alternative Lengthening of Telomeres (ALT) to the Evaluation of Pancreatic Neuroendocrine Tumors (PanNETs)
    Heaphy, Christopher M.
    Singhi, Aatur D.
    HUMAN PATHOLOGY, 2023, 132 : 1 - 11
  • [10] Predicting recurrence in pancreatic neuroendocrine tumours: role of ARX and alternative lengthening of telomeres (ALT)
    Neyaz, Azfar
    Crotty, Rory
    Rickelt, Steffen
    Pankaj, Amaya
    Stojanova, Marija
    Michelakos, Theodoros P.
    Sekigami, Yurie
    Kontos, Filippos
    Parrack, Paige H.
    Patil, Deepa T.
    Heaphy, Christopher M.
    Ferrone, Cristina R.
    Deshpande, Vikram
    HISTOPATHOLOGY, 2023, 83 (04) : 546 - 558